title: Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field study.
abstract: Microscopic detection of parasites has been the reference standard for malaria diagnosis for decades. However, difficulty in maintaining required technical skills and infrastructure has spurred the development of several nonmicroscopic malaria rapid diagnostic devices based on the detection of malaria parasite antigen in whole blood. The ParaSight F test is one such device. It detects the presence of Plasmodium falciparum-specific histidine-rich protein 2 by using an antigen-capture immunochromatographic strip format. The present study was conducted at outpatient malaria clinics in Iquitos, Peru, and Maesod, Thailand. Duplicate, blinded, expert microscopy was employed as the reference standard for evaluating device performance. Of 2,988 eligible patients, microscopy showed that 547 (18%) had P. falciparum, 658 (22%) had P. vivax, 2 (0.07%) had P. malariae, and 1,750 (59%) were negative for Plasmodium. Mixed infections (P. falciparum and P. vivax) were identified in 31 patients (1%). The overall sensitivity of ParaSight F for P. falciparum was 95%. When stratified by magnitude of parasitemia (no. of asexual parasites per microliter of whole blood), sensitivities were 83% (>0 to 500 parasites/microl), 87% (501 to 1,000/microl), 98% (1,001 to 5,000/microl), and 98% (>5,000/microl). Device specificity was 86%.
authors.affiliation: Walter Reed Army Institute of Research, Washington, D.C., USA. mj9173@usma.edu
authors.forename: J R
authors.initials: JR
authors.lastname: Forney
authors.forename: A J
authors.initials: AJ
authors.lastname: Magill
authors.forename: C
authors.initials: C
authors.lastname: Wongsrichanalai
authors.forename: J
authors.initials: J
authors.lastname: Sirichaisinthop
authors.forename: C T
authors.initials: CT
authors.lastname: Bautista
authors.forename: D G
authors.initials: DG
authors.lastname: Heppner
authors.forename: R S
authors.initials: RS
authors.lastname: Miller
authors.forename: C F
authors.initials: CF
authors.lastname: Ockenhouse
authors.forename: A
authors.initials: A
authors.lastname: Gubanov
authors.forename: R
authors.initials: R
authors.lastname: Shafer
authors.forename: C C
authors.initials: CC
authors.lastname: DeWitt
authors.forename: H A
authors.initials: HA
authors.lastname: Quino-Ascurra
authors.forename: K E
authors.initials: KE
authors.lastname: Kester
authors.forename: K C
authors.initials: KC
authors.lastname: Kain
authors.forename: D S
authors.initials: DS
authors.lastname: Walsh
authors.forename: W R
authors.initials: WR
authors.lastname: Ballou
authors.forename: R A
authors.initials: RA
authors.lastname: Gasser
mesh_terms: D000818:Animals; D000953:Antigens, Protozoan / Q000032:analysis*; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D016778:Malaria, Falciparum / Q000175:diagnosis* / Q000469:parasitology; D018512:Parasitemia / Q000175:diagnosis / Q000469:parasitology; D010963:Plasmodium falciparum / Q000302:isolation & purification*; D011506:Proteins / Q000032:analysis*; D011933:Reagent Kits, Diagnostic; D011934:Reagent Strips; D012680:Sensitivity and Specificity; D013997:Time Factors; D000099053:Histidine-Rich Glycoprotein
chemical_list: D000953:Antigens, Protozoan; D011506:Proteins; D011933:Reagent Kits, Diagnostic; D011934:Reagent Strips; D000099053:Histidine-Rich Glycoprotein